SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-017984
Filing Date
2023-05-17
Accepted
2023-05-17 17:13:44
Documents
21
Period of Report
2023-05-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50474
2 ex3-1.htm EX-3.1 3387
3 ex3-2.htm EX-3.2 14517
4 ex99-1.htm EX-99.1 13577
5 ex3-1_001.jpg GRAPHIC 246483
6 ex3-1_002.jpg GRAPHIC 839269
7 ex3-1_003.jpg GRAPHIC 501664
8 ex3-1_004.jpg GRAPHIC 99930
9 ex99-1_001.jpg GRAPHIC 18656
  Complete submission text file 0001493152-23-017984.txt   2657819

Data Files

Seq Description Document Type Size
10 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20230517.xsd EX-101.SCH 3459
11 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20230517_def.xml EX-101.DEF 26186
12 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20230517_lab.xml EX-101.LAB 35952
13 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20230517_pre.xml EX-101.PRE 24844
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4870
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 23932820
SIC: 2834 Pharmaceutical Preparations